Advertisement
Ingenuity
Ingenuity

The Scientist

» public health, evolution and disease/medicine

Most Recent

image: Ebola’s Toll on Healthcare Workers

Ebola’s Toll on Healthcare Workers

By | August 26, 2014

“Unprecedented number of medical staff infected with Ebola,” the World Health Organization says.

2 Comments

image: Social Data for Ebola Surveillance

Social Data for Ebola Surveillance

By | August 26, 2014

Algorithms that map social media posts and mobile phone data can help researchers track epidemics.

0 Comments

image: Chimps Empath-eyes?

Chimps Empath-eyes?

By | August 25, 2014

Chimpanzees may reinforce social bonds by involuntarily mimicking a fellow chimp’s pupil size.

0 Comments

image: Marburg Drug Shows Promise

Marburg Drug Shows Promise

By | August 22, 2014

Monkeys infected with lethal doses of Marburg virus were rescued by an experimental siRNA-based therapeutic, a study shows.

0 Comments

image: For Polio, Two Vaccines Work Better Than One

For Polio, Two Vaccines Work Better Than One

By | August 21, 2014

A booster dose of inactivated polio vaccine bolsters the immune system and reduces viral shedding in children already treated with the oral polio vaccine, a study shows. 

1 Comment

image: How Hummingbirds Taste Nectar

How Hummingbirds Taste Nectar

By | August 21, 2014

Hummingbirds perceive sweetness through a receptor with which other vertebrates taste savory foods. 

0 Comments

image: Obscured Like an Octopus

Obscured Like an Octopus

By | August 21, 2014

Cephalopod skin inspires engineers to design sheets of adaptive camouflage sensors. 

0 Comments

image: DARPA Challenge to Predict Chikungunya Spread

DARPA Challenge to Predict Chikungunya Spread

By | August 19, 2014

Contest aims to identify models that accurately forecast outbreaks.

0 Comments

image: Chikungunya Vaccine Clears Phase 1

Chikungunya Vaccine Clears Phase 1

By | August 18, 2014

Early-stage clinical trial yields promising results. 

0 Comments

image: Biotech Terminates IPO

Biotech Terminates IPO

By | August 15, 2014

The Israeli firm Vascular Biogenics withdrew its initial public offering after six days of trading. 

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
Ingenuity
Ingenuity

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Horizon Discovery
Horizon Discovery
Advertisement
The Scientist
The Scientist
Life Technologies